Stay updated with breaking news from Prnewswire diami. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that it will present a. ....
/PRNewswire/ DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that the company s. ....
/PRNewswire/ DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced the expansion of its. ....
DiamiR Announces Acquisition of CLIA Lab from Interpace Biosciences News provided by Share this article Share this article MONMOUTH JUNCTION, N.J., March 17, 2021 /PRNewswire/ DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into a definitive agreement to acquire a CLIA (Clinical Laboratory Improvement Amendments) certified laboratory in New Haven, CT from Interpace Biosciences, Inc. Subject to specific terms and conditions of the agreement being met, it is anticipated that the transaction will close by the end of April, 2021. Financial terms of this transaction have not been disclosed. ....